CLINICAL_TRIALS
trial_result
· 2017-06-05
Clinical Trial Update: Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma [Phase 3]
Summary
Phase 3 trial evaluating regorafenib after sorafenib in hepatocellular carcinoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2017-06-05